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 17 
Abstract 18 
In human pregnancy the maternal immune system plays a critical role in the 19 
regulation of many aspects of human reproduction including implantation, 20 
placentation and defence against infection. Interest has been focussed on the role of 21 
uterine natural killer cells (uNK) in the maternal decidua whereas effector CD4+ and 22 
CD8+ T cells have received much less attention despite the observation that they 23 
represent a major proportion of decidual leucocytes in the latter phase of pregnancy. 24 
A range of recent studies have demonstrated that human decidual T cells are highly 25 
differentiated, express a range of cytokines and cytotoxic markers, and demonstrate 26 
a unique transcriptional profile characterised by high level expression of genes 27 
involved in interferon-signalling. Moreover, subpopulations of effector T cells 28 
demonstrate specificity for fetal tissue and are regulated through expression of 29 
inhibitory checkpoint proteins and T regulatory cells. Nevertheless, many questions 30 
remain to be answered, such as the potential role of maternal effector T cells in 31 
either supporting successful pregnancy or potentially clearing fetal cells that have 32 
entered the maternal circulation. In addition, there is an increasing interest in the role 33 
of maternal effector T cells in the pathogenesis of disorders such as chronic villitis 34 
miscarriage, stillbirth, fetal growth restriction and pre-eclampsia.  Current debates in 35 
relation to these questions will be discussed within this review. 36 
  37 
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 38 
Maternal effector T cells comprise the major population of leucocytes within 39 
decidua by the end of pregnancy 40 
The maintenance of a semi-allogeneic fetus within the mother represents a 41 
considerable challenge to the maternal immune system during pregnancy [1].  A 42 
wide range of mechanisms have been postulated as being important and have 43 
evolved in order to limit maternal immune recognition of fetal tissue. One of the most 44 
straightforward approaches might have been to exclude effector CD4+ and CD8+ T 45 
cells from the decidual bed.  However, effector T cells represent around 60% of the T 46 
cell pool in the later stages of pregnancy [2] and whilst NK cells are relatively more 47 
numerous in the early stages of pregnancy their numbers remain stable whilst those 48 
of T cells show a gradual increase with advancing gestation [2,3].  As such this 49 
temporal replacement of NK cells by T cells mirrors the kinetics of a peripheral 50 
adaptive immune response and the uterine environment may perhaps be seen to 51 
recapitulate short term lymphocyte dynamics over a 9 month period [4].  CD45RO+ 52 
effector T cells comprise around 60% of the decidual T cell repertoire at term whilst 53 
representing only 30% of T cells within blood. This relative increase in ‘antigen-54 
experienced’ T cells could potentially indicate evidence of local activation although it 55 
may also reflect selective recruitment of effector cells into decidual tissue. In this 56 
regard it is important to compare the phenotypic and functional features of T cells in 57 
the two compartments and this is shown in Table 1. This reveals a number of 58 
differences between effector cells in decidua and blood, including the observation 59 
that decidual effector cells are more highly differentiated than peripheral cells, with 60 
over 40% of such cells demonstrating a CD27-CD28- phenotype compared to less 61 
than 20% in blood [5].  62 
This pattern of local activation of decidual T cells might be taken to represent 63 
recognition of fetal tissue. Fetal trophoblast cells downregulate the expression of 64 
HLA-A and HLA-B, and observation that mismatch of polymorphic HLA-C alleles 65 
between mother and fetus was associated with increased levels of T cell activation 66 
provided some of the first support for this hypothesis [6]. 67 
 68 
The CXCL10-CXCR3 axis is important in attracting effector T cells to decidual 69 
tissue 70 
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Chemokines are important regulators of leukocyte migration and are therefore likely 71 
to play a major role in reproductive biology. CXCR3 is a receptor for inflammatory 72 
chemokines and studies within pregnant mice have shown that it undergoes 73 
epigenetic silencing on T cells within decidua [7], although this may be overcome in 74 
the setting of local inflammation [8].  In contrast our findings reveal CXCR3 to be 75 
expressed on 17% of human decidual CD4+ T cells, one of many differences found 76 
between the immunological environment between mice and humans [5]. CXCL10, an 77 
important ligand for CXCR3, is strongly expressed and identifies the CXCL10-78 
CXCR3 axis as an important mediator of effector cell migration into decidual tissue. 79 
 80 
Maternal effector T cells within decidua can recognize fetal tissue 81 
It is now clear that an adaptive immune response against fetal tissue develops in 82 
most, if not all, human pregnancies. This is indicated most clearly in the development 83 
of alloreactive HLA-specific antibodies and the development of sensitive assays has 84 
revealed that these are found in most mothers following a single pregnancy [9]. 85 
Moreover, the presence of IgG isotypes reveals that antigen-specific T cell ‘help’ has 86 
also been established. The potential importance of these antibodies in relation to 87 
fetal health is uncertain and such responses may simply reflect an epiphenomenon 88 
that is of no consequence to pregnancy outcome. However some studies do reveal a 89 
weak clinical association and HLA-C specific antibodies have been shown to be 90 
more common in women with recurrent fetal loss (miscarriage) [10]. 91 
Given this observation, it is perhaps not surprising that maternal cellular adaptive 92 
immune responses against fetal tissue are also generated during human pregnancy. 93 
Culture and expansion of maternal T cells in vitro first identified cells that were able 94 
to recognise paternal cells [11] and these observations have been substantiated by 95 
techniques that directly visualise T cells with alloreactive potential. Indeed our own 96 
work [12, 13], and that of others [14-16], has identified HY-specific CD8+ T cells in 97 
the maternal circulation following male pregnancies. These CD8 T cells are present 98 
for many years following pregnancy and can be reactivated in vitro to generate highly 99 
cytotoxic T cells that lyze male cells. HY-specific CD8+ cells were detectable in 32% 100 
of women following a single male pregnancy and this proportion rose to 50% of 101 
those with 2 or more male pregnancies, indicating that alloreactive cellular immunity 102 
is boosted by recurrent episodes of fetal microchimerism.  Until recently, it has not 103 
been possible to directly identify T cells with fetal specificity within decidual tissue but 104 
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we have also utilized HLA-peptide multimer technology to identify HY-specific CD8 T 105 
cells in decidual tissue [5].  Indeed, the frequency of such cells is greatly increased 106 
compared to peripheral blood and indicates that cytotoxic cells with specificity for 107 
fetal tissue are localised in direct anatomical contact. 108 
 109 
Effector T cells within decidua display a novel profile of functional activity 110 
Tilbergs et al studied CD8+ effector T cells within decidual tissue and demonstrated 111 
a unique Th1 pattern of high level IFNγ expression together with low levels of 112 
perforin and granzyme [17].  Our own studies of decidual CD4 and CD8+ T cells 113 
confirmed IFNγ expression in many cells but also revealed expression of IL-4 in a 114 
minority population. In particular whilst IFNγ expression was observed in 60% of 115 
CD8+ T cells, 1.2% of cells also expressed IL-4, a value which, whilst relatively 116 
modest, was higher than expression within 0.7% of CD8+ cells within maternal 117 
peripheral blood. Comparable values for CD4+ T cells were 25% and 5% 118 
respectively and Il-4 expression was markedly higher than on maternal T cells from 119 
peripheral blood [5]. Interestingly, Il-4 expression can be induced from peripheral T 120 
cells following incubation with progesterone and this ‘Tprog‘ phenotype may therefore 121 
partially reflect the effect of the local hormonal microenvironment [18, 19]. 122 
We recently completed a comparative transcriptional analysis of effector CD4 and 123 
CD8+ T cells from decidua and maternal peripheral blood.  A wide range of genes 124 
were differentially expressed in decidual T cells with a striking upregulation of those 125 
which encode proteins involved in the signalling response to interferon [5].  This 126 
profile is highly unusual within effector T cells and suggests that decidual tissue is 127 
characterized by high levels of local interferon production. This subject has been 128 
relatively poorly studied although immunohistochemical expression of type 1 129 
interferon has been observed within cells of the monocytic lineage [20,21].  It is 130 
interesting to speculate on what may drive interferon production but it is well 131 
established that endogenous retroviruses play an important role in the generation of 132 
syncytiotrophoblast [22-26]. Notably, the Syncytin-1 protein encoded from the env 133 
gene of ERVW-1 has an essential role in formation of the syncytiotrophoblast and is 134 
released into the periphery via placental microvesicles which are themselves able to 135 
illicit a T cell response [27]. 136 
Effector T cells within decidua demonstrate specificity for pathogens 137 
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Pregnancy is associated with altered regulation of immune responses that can 138 
potentially increase susceptibility to some infectious diseases. The increased 139 
mortality rate of pregnant women following avian influenza infection is one such 140 
example.  As such, it is not surprising that T cells within decidual tissue exhibit 141 
specificity for local pathogens [28].  T cells with specificity for cytomegalovirus and 142 
Epstein-Barr virus are preferentially recruited into decidua and mediate pathogen 143 
surveillance of maternal cells [29]. Importantly, these populations recognise peptides 144 
restricted by HLA-A and HLA-B alleles which are themselves not presented on fetal 145 
trophoblast. Recent investigations have also shown that effector cells can recognise 146 
peptides restricted through HLA-C alleles, potentially indicating efficacy in control of 147 
infected fetal tissue [30]. 148 
 149 
The function of effector T cells is modulated through intrinsic and extrinsic 150 
regulation 151 
The finding of large numbers of functional effector T cells within decidual tissue 152 
raises the question of how such cells are regulated in order to limit potential 153 
immunopathology or fetal damage.  In this regard extrinsic regulation mediated 154 
through T regulatory cells and cell-intrinsic expression of inhibitory checkpoint 155 
proteins are both emerging as important control mechanisms. 156 
T regulatory cells are increased within decidual tissue at term pregnancy and can 157 
comprise over 20% of all CD4+ T cells [31-33].  Indeed, murine experiments have 158 
shown that depletion of T regulatory cells can trigger fetal rejection [34] and it has 159 
been suggested that the evolution of the FoxP3+ T regulatory cell was a key event in 160 
the development of eutherian reproduction [35]. In line with previous reports [33], we 161 
also find that decidual T cells proliferate in response to cord blood lymphocytes and 162 
that this is increased following depletion of T regulatory cells [5]. These observations 163 
indicate that such decidual populations do have specificity for maternal antigens and 164 
that this is at least partly regulated through the action of autologous T regulatory 165 
populations. 166 
Checkpoint proteins such as PD-1 and TIM-3 are now considered to be amongst the 167 
most important molecules within clinical medicine [36, 37].  This is due to the 168 
dramatic efficacy of antibody-mediated blockade of PD-1 function in the treatment of 169 
solid tumours [38]. PD-1 expression on T cells is often taken to represent an 170 
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‘exhausted’ state and is believed to reflect cells that have undergone repeated 171 
stimulation within antigen. However, despite the considerable success of checkpoint 172 
blockade in cancer therapy there is less understanding as to the physiological role of 173 
checkpoint proteins in human T cell physiology.  Interestingly, a high level of 174 
checkpoint protein expression is observed on T cells within decidua [39].  Wang et al 175 
reported large populations of Tim-3+PD-1+ CD8+ T cells within decidua during early 176 
human pregnancy and showed that incubation of CD8 T cells with trophoblast led to 177 
further checkpoint upregulation [40,41]. Interestingly, PD-L1 is expressed on 178 
syncytiotrophoblast, as well as intermediate trophoblastic cells located in the chorion 179 
laeve and implantation site [42], and some studies have indicated that PD-1 180 
blockade in pregnant mice may result in fetal loss [43]. Of note, these observations 181 
provide further evidence that the study of reproductive immunology will be of huge 182 
importance in understanding tumour immunology and lend support to the concept of 183 
cancer as a ‘somatic pregnancy’ [44]. 184 
 185 
Fetal-specific maternal T cells may play a role in limiting fetal microchimerism 186 
It is now generally accepted that pregnancy leads to a state of microchimerism within 187 
the mother in which significant amounts of fetal tissue and cells are released into the 188 
maternal circulation [45].  Moreover, these fetal cells have been shown to survive for 189 
long periods within the mother and have even been implicated in a range of clinical 190 
disorders such as thyroiditis.  Whilst such fetal cells may provide potential benefit to 191 
the mother, such as potentially supporting repair of maternal tissue, it would seem 192 
reasonable that such chimerism would need to be controlled by the maternal 193 
immune system.  In this regard, the humoral and cellular maternal response against 194 
fetal tissue may have an important role in the suppression of fetal chimerism.  195 
Indeed, some support for this hypothesis comes from the observation that the 196 
degree of chimerism has been reported to fall with repeated pregnancies, whilst the 197 
magnitude of fetal-specific immunity appears to increase [46]. These observations 198 
could provide important insights into the regulation of chimerism in disorders such as 199 
transplantation. 200 
 201 
Maternal T cell responses against fetal tissue may be associated with obstetric 202 
complications 203 
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The observation that maternal T cells demonstrate antigenic specificity for fetal 204 
tissue raises the obvious question as to whether these may be implicated in the 205 
pathogenesis of pregnancy complications. Relatively little evidence exists to 206 
implicate maternal T cell responses in the development of pre-eclampsia and this 207 
may reflect the fact that the cardinal feature of impaired trophoblast invasion of 208 
maternal spiral arteries is determined early within pregnancy and at a time when 209 
natural killer cells dominate the cellular infiltrate.  More recently, Leavey et al have 210 
suggested that T cell mediated pathology may indeed be related to a subset of 211 
mothers with preeclampsia who demonstrate a form of disorder characterized by 212 
poor fetal outcome and growth restriction but relatively less impact on maternal 213 
health [47].   214 
Despite this, fetal-specific immunity is strongly implicated in the development of 215 
chronic villitis (‘villitis of uncertain/unknown aetiology’; VUE) which is a relatively 216 
common cause of fetal growth restriction and pre-term delivery [48-51].  VUE is 217 
characterized by an inflammatory cell infiltrate of placental macrophages and T cells 218 
within the villi which develops in the absence of infection.  A specific feature is non-219 
uniform involvement of villi and ultimately this can lead to “obliterative fetal 220 
vasculopathy”.  Interestingly, this maternal infiltrate typically shows a CD8:CD4 ratio 221 
around 3:1 and T cells comprise almost half of the cellular infiltrate.  It has been 222 
suggested that such villitis may represent relatively uncontrolled maternal immune 223 
recognition of fetal tissue and this is supported by the finding that antibodies against 224 
fetal tissue are commonly observed in this disorder and associate with the deposition 225 
of C4 complement components. However caution is needed in this interpretation as 226 
some degree of VUE can been observed in around 10% of pregnancies and as such 227 
this process might even be regarded as a ‘normal variant’. 228 
 229 
Maternal effector T cells represent a fascinating topic for future investigation 230 
Within a relatively short period of time conventional wisdom has moved from the 231 
belief that the placenta represents an effective barrier between the mother and fetus 232 
to an understanding that cells traffic between circulations and immune cells play an 233 
important role in supporting pregnancy. Decidual NK cells have been shown to 234 
possess a range of unique functional properties that represent novel 235 
immunotherapeutic opportunities [52] (Figure 1). Investigation into the physiological 236 
and potential immunopathological role of maternal alloreactive T cells has followed 237 
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more slowly. Despite this, it is now clear that maternal effector CD45RO+ T cells 238 
represent the majority of T cells within decidual tissue in the latter stages of 239 
pregnancy and display a range of novel properties. It remains possible that the 240 
primary role of these cells lies in the control of local infection with no major 241 
significance in relation to reproductive outcome. Nevertheless, further investigation 242 
into the specificity and unique properties of these remarkable cells may uncover 243 
novel insights into the physiology of human placentation, the pathogenesis of 244 
reproductive disorders and offer clues towards a range of additional disorders such 245 
as cancer and transplantation biology. 246 
  247 
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Figure 1.  Representation of maternal effector T cells within decidua and 
their potential functions. These are likely to include (1) recognition of fetal 
antigen or virally-infected EVT through peptides on HLA-C alleles, (2) 
potential access to maternal blood vessels to limit systemic fetal chimerism 
and (3) potential to breach syncytiotrophoblast and damage fetal blood 
vessels 
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Effector T cells within 
decidua 
 
 
Effector T cells within 
maternal peripheral blood 
Percentage of total T cell 
repertoire 
~60% ~30% 
Degree of differentiation more differentiated 
(~40% CD27-CD28-) 
less differentiated 
(~20% CD27-CD28-) 
Pattern of cytokine 
production following 
stimulation with 
PMA/Ionomycin mitogen 
CD4+: 
IFNγ, 25%;  Il-4, 5% 
 
CD8+ 
IFNγ, 60%; Il-4, 1.2% 
CD4+: 
IFNγ, 17% ; Il-4, 2% 
 
CD8+ 
IFNγ, 41% ; Il-4, 0.7% 
Expression of checkpoint 
proteins 
CD4+  
43% PD-1+ 
CD8+  
68% PD-1+ 
CD4+  
20% PD-1+ 
CD8+  
25% PD-1+ 
Frequency of fetal-specific T 
cells 
Use of HLA-peptide 
multimers reveals increased 
numbers compared to blood 
Rare – but potential role in 
controlling fetal chimerism  
Differentially expressed 
genes 
Increase in genes which 
mediate interferon signaling 
response 
 
 
Table 1.  Comparison of the features of CD45RO+ effector T cells within decidua and 
maternal peripheral blood at term.   Data from Powell et al, (Submitted).  
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Figure 1. Representation of maternal effector T cells within decidua and their potential function.
These are likely to include (1) recognition of fetal antigen or virally infected EVT through peptides on
HLA-C alleles, (2) potential access to maternal blood vessels to limit systemic fetal chimerism and (3)
potential to breach damaged syncytiotrophoblast and damage fetal blood vessels
DeciduaFetal villous
Spiral artery
Extravillous trophoblast
Syncytiotrophoblast
3 ?
1 2
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Maternal effector T cells within decidua: the adaptive immune 
response to pregnancy? 
 
 
Lissauer D1, Kilby, MD1. and Moss, P2, 3 
 
Highlights 
 
CD45RO+ effector T cells comprise the majority of CD4+ and 
CD8+ T cells in decidua and are more highly differentiated than 
T cells in blood 
Human effector T cells express CXCR3 which may guide cells to 
decidua 
These cells include populations that can produce IFNγ or Il-4 
Microarray shows that decidual T cells demonstrate a 
transcriptional response to interferon signalling 
T cells proliferate to cord blood indicating a response to fetal 
antigen and this is increased when T regulatory cells are 
removed.  
